O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy. - Ross, P.; Hendlisz, A.; Ajithkumar, T.; Iwuji, C.; Harris, M.; Croagh, D.; Aghmesheh, M.; Nagrial, A.; Nguyen, N.; Nikfarjam, M.; Wilson, N.; Kenny, D.; et al. (Annals of Oncology, 2020)